Updated 2 October 2026 · Aurelis Peptides
Sermorelin is a peptide that stimulates growth hormone release. It belongs to the family of signals that tell the pituitary gland to release this hormone. The simple idea is a releasing signal followed by the body’s hormone response.
Aurelis lists Sermorelin 10 mg for product enquiries.
| Main interest | Growth hormone release |
|---|---|
| What studies looked at | The body’s hormone response to a releasing peptide |
| Study context | A small human hormone-response study |
| Listed content | 10 mg per unit |
What did the human study find?
A study compared three lengths of growth hormone-releasing peptide in five healthy volunteers. All three increased growth hormone levels compared with placebo. The shorter 29-amino-acid version is the form relevant to sermorelin. Read the hormone-response study.
- Growth hormone release was directly measured.
- The study compared shorter and longer releasing peptides.
- The largest hormone increases did not significantly differ between those lengths.
How to understand the peptide’s role
Sermorelin is the releasing peptide in this explanation. Growth hormone is the hormone measured after that signal. The official molecular name identifies sermorelin as the 1–29 fragment of growth hormone-releasing hormone. See the peptide definition.
That is the main action behind interest in sermorelin. The study above measured the immediate hormone response to a releasing signal.
Explore Sermorelin 10 mg
Open the Sermorelin catalogue profile to see the listed 10 mg content per unit. You can also explore Tesamorelin’s abdominal-fat research, another topic involving growth-hormone release.
Explore Sermorelin with Aurelis
Ask our team about Sermorelin 10 mg, your preferred presentation, local availability and available batch documents.
Aurelis holds stock in Australia, Canada and the USA. Tell us your destination so our team can check local availability.
Enquire about Sermorelin · Open the Sermorelin catalogue profile